Clinical Trials Browser

Phase 3 × INDUSTRY × enzastaurin × Clear all

NCT00332202 2018-09-10

PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

Phase 3 Completed

758 enrolled 20 charts

Lymphoma, Non-Hodgkin